{
  "id": 17051341,
  "title": "Senores Pharmaceuticals Sees Strong Q2 FY27 With 25% Revenue Jump, EBITDA Climbing 38% Amidst Portfolio Expansion",
  "url": "https://urgent.news/2026/10/29/senores-pharmaceuticals-sees-strong-q2-fy27-with-25-revenue-jump",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-29T10:25:48.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/senores-pharmaceuticals-sees-strong-q2-fy27-with-25-revenue-jump-ebitda-climbing-38-amidst-portfolio-expansion"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mumbai: Senores Pharmaceuticals Limited on Wednesday, 29 October 2026, reported its unaudited financial results for the quarter and half year ended 30 September 2026. The company's revenue for the second quarter of fiscal year 2027 grew by 25% year-on-year to ₹192 crore. Profitability Growth Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) for Q2 FY27 increased by 38%…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}